Recombinant human Coagulation Factor VIII-Fc fusion protein for injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant human Coagulation Factor VIII-Fc fusion protein for injection, covering 2023-12-13 to 2023-12-13. Get the full timeline:
Most recent: Clinical Trial Update: An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A. [Phase 3]